Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion type Assertion NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_head.
- NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_provenance.
- NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion evidence source_evidence_literature NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_provenance.
- NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion SIO_000772 21270202 NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_provenance.
- NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion wasDerivedFrom befree-20140225 NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_provenance.
- NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion wasGeneratedBy ECO_0000203 NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_provenance.